GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop dangerous transplant complication in kids
Disease control Not yet recruitingThis study is testing whether adding the drug vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults receiving bone marrow transplants for non-cancerous blood disorders. Researchers will enroll 55 patients aged 1-26 yea…
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Stanford tests bold move: stop rejection drug early after transplant
Disease control Not yet recruitingThis study aims to see if it's safe and possible to stop a key anti-rejection medication (tacrolimus) much earlier than usual after a bone marrow transplant. It will involve 50 adults with various blood cancers who receive a transplant from a matched donor. The goal is to reduce …
Matched conditions: GVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC